BioSenic S.A. (BIOS) - Total Liabilities

Latest as of June 2025: €28.10 Million EUR ≈ $32.85 Million USD

Based on the latest financial reports, BioSenic S.A. (BIOS) has total liabilities worth €28.10 Million EUR (≈ $32.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BioSenic S.A. operating cash flow efficiency to assess how effectively this company generates cash.

BioSenic S.A. - Total Liabilities Trend (2011–2024)

This chart illustrates how BioSenic S.A.'s total liabilities have evolved over time, based on quarterly financial data. Check BIOS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

BioSenic S.A. Competitors by Total Liabilities

The table below lists competitors of BioSenic S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
Anatara Lifesciences Ltd AU:ANR	Australia	AU$612.42K
Lazydays Holdings Inc NASDAQ:GORV	USA	$359.47 Million
WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK	USA	$11.99 Million
Trufin PLC LSE:TRU	UK	GBX18.69 Million
Foxtons Group Plc LSE:FOXT	UK	GBX124.82 Million
Shirpur Gold Refinery Limited NSE:SHIRPUR-G	India	Rs7.39 Billion
Oncternal Therapeutics Inc NASDAQ:ONCT	USA	$6.45 Million
Golden Cross Resources Ltd AU:GCR	Australia	AU$9.79 Million

Liability Composition Analysis (2011–2024)

This chart breaks down BioSenic S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BIOS market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	6.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioSenic S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioSenic S.A. (2011–2024)

The table below shows the annual total liabilities of BioSenic S.A. from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€31.55 Million ≈ $36.89 Million	-2.21%
2023-12-31	€32.26 Million ≈ $37.72 Million	+23.15%
2022-12-31	€26.20 Million ≈ $30.63 Million	-1.27%
2021-12-31	€26.54 Million ≈ $31.02 Million	+23.37%
2020-12-31	€21.51 Million ≈ $25.15 Million	+5.73%
2019-12-31	€20.34 Million ≈ $23.79 Million	-4.31%
2018-12-31	€21.26 Million ≈ $24.86 Million	-6.70%
2017-12-31	€22.79 Million ≈ $26.64 Million	-2.25%
2016-12-31	€23.32 Million ≈ $27.26 Million	+4.85%
2015-12-31	€22.24 Million ≈ $26.00 Million	-33.99%
2014-12-31	€33.69 Million ≈ $39.38 Million	+164.25%
2013-12-31	€12.75 Million ≈ $14.90 Million	+8.22%
2012-12-31	€11.78 Million ≈ $13.77 Million	+4.79%
2011-12-31	€11.24 Million ≈ $13.14 Million	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#29899 Global

#110 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66